Gerlind Holberg
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
An External Control Arm for the Oral Factor XIa Inhibitor Asundexian Phase 2 Trial in Atrial Fibrillation (PACIFIC-AF) Using Electronic Health Records.
Journal: Cardiology and therapy
Published: February 06, 2025
Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.
Journal: Journal of the American College of Cardiology
Published: August 16, 2023
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
Journal: The New England journal of medicine
Published: March 21, 2017
Rivaroxaban for thrombosis prophylaxis in extensive hip and knee operations. Subanalysis of the German cohort (XAMOS-DE) of non-interventional study XAMOS
Journal: MMW Fortschritte der Medizin
Published: January 17, 2017
The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study.
Journal: Vascular health and risk management
Published: June 09, 2016
Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: September 27, 2015
Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactions.
Journal: British journal of clinical pharmacology
Published: July 31, 2015
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study.
Journal: Thrombosis and haemostasis
Published: February 18, 2015
Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty.
Journal: The Journal of bone and joint surgery. American volume
Published: February 21, 2014
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment.
Journal: Thrombosis and haemostasis
Published: August 14, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026